Why Biomedical Treatment for Autism?
Traditional treatment of autism was mainly through psychotic drugs, which treated only symptoms but not the underlying physiological conditions. In the last 20 years, the focus has gradually shifted to the “Biomedical Treatment for Autism.” This new approach looks at the “comorbid conditions of autism” (a termed coined by psychologists), meaning physiological conditions that tend to coexist with autism. Many individuals with autism shared these conditions, which range from gastroenterological, hormonal, methylation, to immune and autoimmune problems.
There are many books out there that explain the principles of Biomedical Treatment for Autism (you can just google this term). In a nutshell, a predominant theory holds that many individuals on the autism spectrum have a weakened immune system due partly to innate predisposition and partly to environmental assaults. This allows pathogens and toxins to disrupt the GI track and result into neurological, hormonal, methylation, and autoimmune damages. When the amount of these damages crosses the threshold, they can lead to symptoms known as autism. The Biomedical Treatment seeks to remove the pathogens and toxins and control their damages. When the patient’s health is restored, improvement in behavior often ensues.
As scientific evaluations of biomedical treatment are underway, a medical board has been established to certify M.D.s who are qualified to provide Biomedical Treatment. The annual Autism One conference, the largest conference on autism in the world, devotes most of its panels on Biomedical Treatment, with “recovery” being the buzz word in recent years. In addition, parents across the world have been reporting their children’s positive responses to the treatment. Success stories are shared daily on dozens of internet support groups.
For more information on Biomedical Treatment for Autism, including its general principles and ongoing research, you can visit these sites: